These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22886469)

  • 1. Primary Sjögren's syndrome and B-non-Hodgkin lymphoma: role of CD4+ T lymphocytopenia.
    Ismail F; Mahmoud A; Abdelhaleem H; Mamdoh A; Geneidy M; Kamal E
    Rheumatol Int; 2013 Apr; 33(4):1021-5. PubMed ID: 22886469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+ T-lymphocytopenia--a frequent finding in anti-SSA antibody seropositive patients with primary Sjögren's syndrome.
    Mandl T; Bredberg A; Jacobsson LT; Manthorpe R; Henriksson G
    J Rheumatol; 2004 Apr; 31(4):726-8. PubMed ID: 15088298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren's Syndrome.
    Chatzis L; Goules AV; Stergiou IE; Voulgarelis M; Tzioufas AG; Kapsogeorgou EK
    Front Immunol; 2021; 12():705079. PubMed ID: 34484201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18.
    Ciccia F; Guggino G; Rizzo A; Bombardieri M; Raimondo S; Carubbi F; Cannizzaro A; Sireci G; Dieli F; Campisi G; Giacomelli R; Cipriani P; De Leo G; Alessandro R; Triolo G
    Clin Exp Immunol; 2015 Aug; 181(2):219-29. PubMed ID: 25880879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ T-lymphocytopenia without HIV infection: increased prevalence among patients with primary Sjögren's syndrome.
    Kirtava Z; Blomberg J; Bredberg A; Henriksson G; Jacobsson L; Manthorpe R
    Clin Exp Rheumatol; 1995; 13(5):609-16. PubMed ID: 8575139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant IL-35 levels in patients with primary Sjogren's syndrome.
    Guo J; Gu M; Zhang W; Liu Y; Qian C; Deng A
    Scand J Immunol; 2018 Nov; 88(5):e12718. PubMed ID: 30589451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic CD4+ T-lymphocytopenia in a non-Hodgkin's lymphoma patient.
    Hanamura I; Wakita A; Harada S; Tsuboi K; Komatsu H; Banno S; Iwaki O; Takeuchi G; Nitta M; Ueda R
    Intern Med; 1997 Sep; 36(9):643-6. PubMed ID: 9313110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-Cell RNA Sequencing Reveals the Expansion of Cytotoxic CD4
    Hong X; Meng S; Tang D; Wang T; Ding L; Yu H; Li H; Liu D; Dai Y; Yang M
    Front Immunol; 2020; 11():594658. PubMed ID: 33603736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren's syndrome.
    Traianos EY; Locke J; Lendrem D; Bowman S; Hargreaves B; Macrae V; ; Tarn JR; Ng WF
    Rheumatol Int; 2020 Apr; 40(4):541-548. PubMed ID: 32047959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased percentage of CD8+CD28- T cells correlates with clinical activity in primary Sjögren's syndrome.
    Smoleńska Z; Pawłowska J; Zdrojewski Z; Daca A; Bryl E
    Cell Immunol; 2012; 278(1-2):143-51. PubMed ID: 22975109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
    Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
    Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased frequency of CCR7
    Wu C; Yang P; Liu H; Xiao W; Zhao L
    Cytokine; 2018 Oct; 110():9-17. PubMed ID: 29684636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCL5 Release by CCR9+ CD8 T Cells: A Potential Contributor to Immunopathology of Primary Sjögren's Syndrome.
    Hinrichs AC; Blokland SLM; Kruize AA; Lafeber FPJ; Leavis HL; van Roon JAG
    Front Immunol; 2022; 13():887972. PubMed ID: 35720379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 cytopenia and occasional expansion of CD4+CD8+lymphocytes in Sjögren's syndrome.
    Ferraccioli GF; Tonutti E; Casatta L; Pegoraro I; De Vita S; Sala P; Ravaioli T; Bartoli E
    Clin Exp Rheumatol; 1996; 14(2):125-30. PubMed ID: 8737717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of CD226/TIGIT immune checkpoint on T cells in the pathogenesis of primary Sjögren's syndrome.
    Deng C; Chen Y; Li W; Peng L; Luo X; Peng Y; Zhao L; Wu Q; Zhang W; Zhang X; Fei Y
    J Autoimmun; 2020 Sep; 113():102485. PubMed ID: 32466852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome.
    Gottenberg JE; Lavie F; Abbed K; Gasnault J; Le Nevot E; Delfraissy JF; Taoufik Y; Mariette X
    J Autoimmun; 2005 May; 24(3):235-42. PubMed ID: 15848046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4 T lymphocyte autophagy is upregulated in the salivary glands of primary Sjögren's syndrome patients and correlates with focus score and disease activity.
    Alessandri C; Ciccia F; Priori R; Astorri E; Guggino G; Alessandro R; Rizzo A; Conti F; Minniti A; Barbati C; Vomero M; Pendolino M; Finucci A; Ortona E; Colasanti T; Pierdominici M; Malorni W; Triolo G; Valesini G
    Arthritis Res Ther; 2017 Jul; 19(1):178. PubMed ID: 28743286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.
    Quartuccio L; Isola M; Baldini C; Priori R; Bartoloni Bocci E; Carubbi F; Maset M; Gregoraci G; Della Mea V; Salvin S; De Marchi G; Luciano N; Colafrancesco S; Alunno A; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
    J Autoimmun; 2014 Jun; 51():75-80. PubMed ID: 24231556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal expression of apoptosis-related antigens, Fas and bcl-2, on circulating T-lymphocyte subsets in primary Sjögren's syndrome.
    Ichikawa Y; Arimori K; Yoshida M; Horiki T; Hoshina Y; Morita K; Uchiyama M; Shimizu H; Moriuchi J; Takaya M
    Clin Exp Rheumatol; 1995; 13(3):307-13. PubMed ID: 7554556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic role of CXCL13 biomarker in primary Sjogren's syndrome patients with parotid non-Hodgkin's lymphoma complication.
    Badarinza M; Serban O; Maghear L; Pelea MA; Rosca RI; Fodor D; Stancu B
    Med Clin (Barc); 2023 Jun; 160(11):484-488. PubMed ID: 37005121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.